FR · biotech · immunotherapy · oncology
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Seed · May 2026 · €11 million
Taiho Ventures lead, Sofinnova Partners, Invivo Partners
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.